Pain, fatigue, nausea, and vomiting as the predictors of anxiety in patients undergoing hematopoietic stem cell transplantation: a prospective cohort study

N Pasyar, M Rambod, F Zahedi, M Ramzi - Supportive Care in Cancer, 2022 - Springer
The primary outcome was to assess the correlation between anxiety and pain, fatigue,
nausea, and vomiting. The secondary outcome was to determine the predictive roles of pain …

Aprepitant for cough suppression in advanced lung cancer: a randomized trial

V Noronha, A Bhattacharjee, VM Patil, A Joshi… - Chest, 2020 - Elsevier
Background Although cough is a common and distressing symptom in patients with lung
cancer, there is almost no evidence to guide treatment. Aprepitant, a centrally acting …

[HTML][HTML] Влияние гидрокарбоната натрия на формирование гастростаза у крыс при моделировании миелоабляционной химиотерапии циклофосфаном

ОА Вакуненкова, ЮЮ Ивницкий… - Медицина …, 2023 - cyberleninka.ru
При миелоабляционной цитостатической терапии нередко возникает желудочно-
кишечный стаз (ЖКС)—звено патогенеза синдрома избыточного бактериального …

[HTML][HTML] Long-Term Daily Administration of Aprepitant for the Management of Intractable Nausea and Vomiting in Children With Life-Limiting Conditions: A Case …

B Patel, J Downie, J Bayliss, A Stephenson… - Journal of Pain and …, 2021 - Elsevier
Background Nausea and vomiting is a common symptom in children through their end of life
journey. Aprepitant, a NK-1 antagonist, has become a potent weapon in the fight against …

Use of long term aprepitant as a treatment for refractory nausea following oesophageal stent insertion–a case report

R Shoulder, J Taylor, H Stiel - Palliative Medicine, 2022 - journals.sagepub.com
Background: Aprepitant, a substance P neurokinin-1 receptor antagonist, is licenced for the
prevention of acute and delayed nausea and vomiting associated with highly and …

[HTML][HTML] Gastroparesis as a significant gastrointestinal adverse event during intensive chemotherapy for solid caner: a case report

T Nakayama, K Haratani, T Kurosaki… - Translational Cancer …, 2022 - ncbi.nlm.nih.gov
Background Proper management of chemotherapy-related gastrointestinal toxicities is
essential to maximize therapeutic outcome for malignancies. Gastroparesis is an onerous …

[PDF][PDF] EFFECT OF SODIUM BICARBONATE ON THE DEVELOPMENT OF GASTRIC STASIS IN THE RAT MODEL OF MYELOABLATIVE CHEMOTHERAPY WITH …

OA Vakunenkova, I JuJu, ON Gaykova, AA Kozlov… - mes.fmba.press
METHODS The study involved 140 male Wistar rats (161–190 g) obtained from the
Rappolovo laboratory animal nursery. The animals were treated in accordance with the …

Экстренная профилактика гастростаза у крыс при моделировании миелоабляционной химиотерапии циклофосфаном

ОА Вакуненкова, ЮЮ Ивницкий, КА Краснов… - medline.ru
Резюме Изучали влияние вводимого в желудок гидрокарбоната натрия (NaHCO3) на
формирование желудочно-кишечного стаза, острого цитостатического мукозита …

Medline. ru СОДЕРЖАНИЕ ЖУРНАЛА

OA Vakunenkova, IJ Ju, KA Krasnov, AA Krasnova - medline.ru
The effect of sodium bicarbonate (NaHCO3) administered by gavage on the formation of
gastrointestinal stasis and urinary indican excretion was studied in a rat model of …

[PDF][PDF] 위마비증과만성구역구토증후군환자에서Aprepitant 의효과

정경원, 박무인 - 대한소화기학회지, 2018 - pdfs.semanticscholar.org
위마비증 (gastroparesis) 이나 만성 구역 구토 증후군 (chronic unexplained nausea and
vomiting) 으로 인한 구역과 구토에 대한 치료는 일반적으로 사용하는 위장관 촉진제에 …